Ferozsons Laboratories Limited (PSX:FEROZ)
390.04
-10.97 (-2.74%)
At close: Nov 11, 2025
Ferozsons Laboratories Revenue
Ferozsons Laboratories had revenue of 5.94B PKR in the quarter ending September 30, 2025, with 31.14% growth. This brings the company's revenue in the last twelve months to 20.27B, up 27.03% year-over-year. In the fiscal year ending June 30, 2025, Ferozsons Laboratories had annual revenue of 18.86B with 18.94% growth.
Revenue (ttm)
20.27B
Revenue Growth
+27.03%
P/S Ratio
0.84
Revenue / Employee
13.03M
Employees
1,556
Market Cap
16.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 18.86B | 3.00B | 18.94% |
| Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
| Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
| Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
| Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |
| The Searle Company | 30.67B |
| Shifa International Hospitals | 28.52B |
| AGP Limited | 27.73B |
| Highnoon Laboratories | 26.61B |
| Citi Pharma | 13.30B |
| Macter International | 10.96B |